• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于爱泼斯坦-巴尔病毒衍生载体的第一代包装细胞系。

A first-generation packaging cell line for Epstein-Barr virus-derived vectors.

作者信息

Delecluse H J, Pich D, Hilsendegen T, Baum C, Hammerschmidt W

机构信息

GSF-National Research Center for Environment and Health, Institute of Clinical Molecular Biology and Tumor Genetics, Department Gene Vectors, Marchioninistrasse 25, D-81377 Munich, Germany.

出版信息

Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5188-93. doi: 10.1073/pnas.96.9.5188.

DOI:10.1073/pnas.96.9.5188
PMID:10220441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC21839/
Abstract

On the basis of the B lymphotropic Epstein-Barr virus (EBV), we have constructed a virus-free packaging cell line that allows encapsidation of plasmids into herpesvirus particles. This cell line harbors an EBV mutant whose packaging signals have been deleted. The gene vectors, which can encompass very large, contiguous pieces of foreign DNA, carry all cis-acting elements involved in amplification and encapsidation into virus-like particles as well as those essential for extrachromosomal maintenance in the recipient cell. Although this first-generation packaging cell line suffers from unwanted recombination between the helper virus genome and gene vector DNAs, this approach opens the way to delivery and stable maintenance of any transgene in human B cells.

摘要

基于嗜B淋巴细胞的爱泼斯坦-巴尔病毒(EBV),我们构建了一种无病毒包装细胞系,该细胞系可将质粒包装到疱疹病毒颗粒中。此细胞系含有一个EBV突变体,其包装信号已被删除。基因载体可包含非常大的连续外源DNA片段,携带所有参与扩增和包装到病毒样颗粒中的顺式作用元件,以及受体细胞中染色体外维持所必需的元件。尽管这种第一代包装细胞系存在辅助病毒基因组与基因载体DNA之间不必要的重组问题,但这种方法为在人B细胞中递送和稳定维持任何转基因开辟了道路。

相似文献

1
A first-generation packaging cell line for Epstein-Barr virus-derived vectors.一种用于爱泼斯坦-巴尔病毒衍生载体的第一代包装细胞系。
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5188-93. doi: 10.1073/pnas.96.9.5188.
2
Genetic design of an optimized packaging cell line for gene vectors transducing human B cells.用于转导人B细胞的基因载体的优化包装细胞系的基因设计。
Gene Ther. 2006 May;13(10):844-56. doi: 10.1038/sj.gt.3302714.
3
High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors.使用无辅助病毒的重组爱泼斯坦-巴尔病毒载体在原发性慢性淋巴细胞白血病细胞中实现高水平转基因表达。
Exp Hematol. 2003 Feb;31(2):99-108. doi: 10.1016/s0301-472x(02)01019-6.
4
Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.绘制爱泼斯坦-巴尔病毒的遗传元件图谱,这些元件有助于爱泼斯坦-巴尔病毒衍生质粒在人类细胞中的染色体外持久性。
Mol Cell Biol. 1985 Oct;5(10):2533-42. doi: 10.1128/mcb.5.10.2533-2542.1985.
5
Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector.通过爱泼斯坦-巴尔病毒扩增子载体进行120千碱基基因组DNA的感染性递送。
Mol Ther. 2002 Apr;5(4):427-35. doi: 10.1006/mthe.2002.0557.
6
Development of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.一种用于哺乳动物细胞稳定转化的新型辅助依赖型腺病毒-爱泼斯坦-巴尔病毒杂交系统的开发。
J Virol. 2004 Jun;78(12):6556-66. doi: 10.1128/JVI.78.12.6556-6566.2004.
7
The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.爱泼斯坦-巴尔病毒的遗传学研究方法:从基础病毒学到基因治疗
Mol Pathol. 2000 Oct;53(5):270-9. doi: 10.1136/mp.53.5.270.
8
Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.病毒重组体在针对爱泼斯坦-巴尔病毒免疫反应研究中的作用。
Semin Cancer Biol. 2008 Dec;18(6):409-15. doi: 10.1016/j.semcancer.2008.09.001. Epub 2008 Sep 30.
9
Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein-Barr virus.
Nat Med. 1995 Dec;1(12):1303-8. doi: 10.1038/nm1295-1303.
10
Development of a competitive PCR method for physical titration of recombinant EBV vector in a helper-dependent packaging system.
Mol Ther. 2001 Jun;3(6):976-83. doi: 10.1006/mthe.2001.0326.

引用本文的文献

1
Alternative splicing in the RBMXL1 5'-UTR induces uORF-mediated translation control in activated B lymphocytes.RBMXL1 5'-非翻译区的可变剪接在活化B淋巴细胞中诱导uORF介导的翻译调控。
Sci Rep. 2025 Jul 2;15(1):22800. doi: 10.1038/s41598-025-03274-3.
2
Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis.评价新型 Epstein-Barr 病毒衍生抗原制剂在监测传染性单核细胞增多症患儿病毒特异性 T 细胞中的作用。
Virol J. 2024 Jun 14;21(1):139. doi: 10.1186/s12985-024-02411-0.
3
Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized Mice.经 EBV 永生化的源自免疫人源化小鼠的脾细胞产生的完全人疱疹病毒特异性中和 IgG 抗体。
Cells. 2023 Dec 21;13(1):20. doi: 10.3390/cells13010020.
4
SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests.在病毒中和试验中,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)和爱泼斯坦-巴尔病毒样颗粒与细胞外囊泡结合并融合。
Biomedicines. 2023 Oct 25;11(11):2892. doi: 10.3390/biomedicines11112892.
5
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.鼻咽癌精准医学:过去、现在和未来展望的全面综述。
J Transl Med. 2023 Nov 6;21(1):786. doi: 10.1186/s12967-023-04673-8.
6
Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model.使用兔模型评估基于病毒样颗粒的疫苗对 Epstein-Barr 病毒的疗效。
Vaccines (Basel). 2023 Feb 24;11(3):540. doi: 10.3390/vaccines11030540.
7
EBV-associated diseases: Current therapeutics and emerging technologies.EBV 相关疾病:当前的治疗方法和新兴技术。
Front Immunol. 2022 Oct 27;13:1059133. doi: 10.3389/fimmu.2022.1059133. eCollection 2022.
8
25-Hydroxycholesterol Inhibits Kaposi's Sarcoma Herpesvirus and Epstein-Barr Virus Infections and Activates Inflammatory Cytokine Responses.25-羟基胆固醇抑制卡波西肉瘤疱疹病毒和 Epstein-Barr 病毒感染并激活炎症细胞因子反应。
mBio. 2021 Dec 21;12(6):e0290721. doi: 10.1128/mBio.02907-21. Epub 2021 Nov 16.
9
Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein.在人类原发性 B 淋巴细胞被 EBV(Epstein-Barr virus)早期感染期间的可变剪接调控:病毒 EBNA-LP 蛋白的新功能。
Nucleic Acids Res. 2021 Oct 11;49(18):10657-10676. doi: 10.1093/nar/gkab787.
10
Overview of virus and cancer relationships. Position paper.病毒与癌症关系概述。立场文件。
Rev Esp Quimioter. 2021 Dec;34(6):525-555. doi: 10.37201/req/058.2021. Epub 2021 Aug 5.

本文引用的文献

1
Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells.完整、具有感染性的爱泼斯坦-巴尔病毒从原核细胞到人类细胞的传播与复苏。
Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8245-50. doi: 10.1073/pnas.95.14.8245.
2
Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.爱泼斯坦-巴尔病毒介导的B细胞增殖依赖于潜伏膜蛋白1,该蛋白模拟活化的CD40受体。
EMBO J. 1998 Mar 16;17(6):1700-9. doi: 10.1093/emboj/17.6.1700.
3
Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.作为一种感染性细菌人工染色体的疱疹病毒基因组的克隆与诱变
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14759-63. doi: 10.1073/pnas.94.26.14759.
4
Rapid proliferation of B cells from adenoids in response to Epstein-Barr virus infection.腺样体中的B细胞对爱泼斯坦-巴尔病毒感染作出反应而迅速增殖。
Cancer Res. 1996 Dec 15;56(24):5610-4.
5
Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.
Hum Gene Ther. 1995 Nov;6(11):1363-77. doi: 10.1089/hum.1995.6.11-1363.
6
Development and application of herpes simplex virus vectors for human gene therapy.用于人类基因治疗的单纯疱疹病毒载体的开发与应用。
Annu Rev Microbiol. 1995;49:675-710. doi: 10.1146/annurev.mi.49.100195.003331.
7
Biochemistry of multidrug resistance mediated by the multidrug transporter.多药转运蛋白介导的多药耐药的生物化学
Annu Rev Biochem. 1993;62:385-427. doi: 10.1146/annurev.bi.62.070193.002125.
8
Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA.用含有71千碱基对的爱泼斯坦-巴尔病毒DNA的质粒使人B淋巴细胞永生化。
J Virol. 1995 Jan;69(1):231-8. doi: 10.1128/JVI.69.1.231-238.1995.
9
Optimal lengths for DNAs encapsidated by Epstein-Barr virus.爱泼斯坦-巴尔病毒包裹的DNA的最佳长度
J Virol. 1994 Dec;68(12):8217-22. doi: 10.1128/JVI.68.12.8217-8222.1994.
10
Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA.爱泼斯坦-巴尔病毒末端重复序列在病毒体DNA加工与包装中的结构和作用
J Virol. 1995 May;69(5):3147-55. doi: 10.1128/JVI.69.5.3147-3155.1995.